Sign in
TerminatedNo phase

A Multi-Disciplinary Technology-Based Care for Diabetic Ketoacidosis in Patients With Type 1 Diabetes

Key facts

Who runs it
The Cleveland Clinic
Where
Cleveland, United StatesSee the site
Trial code
Status
Terminated
People taking part
2 people enrolled
Started
15 Nov 2024
Ended
1 Nov 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Continuous Glucose Monitoring (CGM)
  • Standard of Care
Record updated
20 February 2026
Why it stopped
Recruitment was too difficult - not enough patients were enrolled after 1 year

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Age 18 years old or older
  • Diagnosis of Type 1 Diabetes
  • Admitted to the hospital with confirmed DKA as determined by emergency department or admitting team
  • Compatible smart phone with the Libre 3
  • Active insurance plan

Who cannot take part

  • Allergy to any component of the Libre 3
  • Condition which, in investigator judgement would limit their ability to participate safely

Where in United States

  • The Cleveland Clinic FoundationCleveland, United States

About the trial

What the trial wants to find out

The study team proposes that use of a novel multi-disciplinary approach with continuous glucose monitoring technology can significantly improve glycemic control and reduce readmissions among those with type 1 diabetes mellitus (T1DM) admitted for Diabetic ketoacidosis (DKA). This will also help promote a pathway for care of these patients after admission utilizing resources which are available within the Endocrinology, Diabetes and Metabolism department at the Cleveland Clinic.

The 2 groups in the trial

  • Control Arm - Standard of Care, retrospectiveOther group

    Retrospective data looking at 12 patients undergoing standard of care for diabetic ketoacidosis

    Treatment: Standard of Care

  • Intervention Arm - Continuous Glucose Monitoring (CGM)Existing treatment, for comparison

    12 patients with confirmed diabetic ketoacidosis upon hospital admission will receive continuous glucose monitor (CGM)

    Treatment: Continuous Glucose Monitoring (CGM)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multi-Disciplinary Technology-Based Care After Hospitalization for Diabetic Ketoacidosis in Patients With Type 1 Diabetes
Record updated
20 February 2026